We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

In trading on Tuesday, shares of Denali Therapeutics Inc (Symbol: DNLI) crossed above their 200 day moving average of $23.11, changing hands as high as $23.33 per share. Denali Therapeutics Inc ...

William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...

Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained 26.6% against the industry’s decline of 14.3%. The stock has also ...

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) was the recipient of a significant growth in short interest in the month of December.As of December 31st, there was short interest ...

DNLI opened at $21.25 on Tuesday. The stock has a fifty day moving average of $24.23 and a 200-day moving average of $24.86. Denali Therapeutics has a fifty-two week low of $14.56 and a fifty-two ...

Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) gapped down prior to trading on Tuesday after JPMorgan Chase & Co. lowered their price target on the stock from $28.00 to $24.00.

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) shares traded down 4.1% on Monday following insider selling activity. The stock traded as low as $20.25 and last traded at $20.39.